Review



primary antibody mouse anti 10e4  (AMS Biotechnology)


Bioz Verified Symbol AMS Biotechnology is a verified supplier
Bioz Manufacturer Symbol AMS Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    AMS Biotechnology primary antibody mouse anti 10e4
    (A) Schematic of the tau uptake assay in iPSC-derived astrocytes. (B) Representative overlaid histograms demonstrating the shift in fluorescence of cells with AF647 labeled tau (2N4R-P301L) aggregates (50nM, 3h) compared to cells treated with PBS. The dotted line represents the median AF647 intensity in the WT astrocytes treated with Tau. (C) Measurement of tau uptake by flow cytometry normalized to cells treated with PBS (n=3, 10000 cells each). (D) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of heparin normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 100 ug/ml heparin against cells with no treatment for each cell line. (E) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of RAP normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 500 nM RAP against cells with no treatment for each cell line. (F) Representative images of iPSC-derived astrocytes immunolabeled with <t>anti-10E4,</t> an HSPG marker. Green, 10E4; blue, Hoechst 33342; scale bar = 10 µm (G) Quantification of the expression of HSPGs using fluorescence intensity of anti-10E4 normalized to that of Hoechst per field of view (n=24 FOVs taken from 8 biological replicates, 3 FOVs per biological replicate) (H) Quantification of the expression of HSPG-related genes with RNA sequencing (n=3 for WT and n=6 for APOE3-Ch). Z-score of each HSPG gene is color coded and the size of the circle represents the mean expression. P-values were calculated using a Wald test for differential expression between groups (WT vs APOE3-Ch). Multiple testing correction was performed using the Benjamini-Hochberg method to control the false discovery rate (FDR). Genes with an adjusted p-value < 0.05 were considered statistically significant. Significantly upregulated genes were marked by red asterisks and significantly downregulated genes were marked by blue asterisks. (I) Representative images of iPSC-derived astrocytes immunolabeled with anti-LRP1. Green, LRP1; blue, Hoechst 33342; scale bar = 10 µm (J) Quantification of the expression of LRP1 using fluorescence intensity of anti-LRP1 normalized to that of Hoechst per field of view (n=12 FOVs taken from 4 biological replicates, 3 FOVs per biological replicate) All data are expressed as mean ± s.d. with individual data points shown. One-way ANOVA with Dunnett’s multiple comparison tests was performed to determine the significance unless otherwise specified. The results designated as “ns” are not significant; **p<0.01; ***p<0.001;****p<0.0001
    Primary Antibody Mouse Anti 10e4, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 98/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/9067/bio_rxiv__2025__01__21__634115-360-4-8?v=AMS+Biotechnology
    Average 98 stars, based on 11 article reviews
    primary antibody mouse anti 10e4 - by Bioz Stars, 2026-07
    98/100 stars

    Images

    1) Product Images from "Protective mechanisms against Alzheimer’s Disease in APOE3-Christchurch homozygous astrocytes"

    Article Title: Protective mechanisms against Alzheimer’s Disease in APOE3-Christchurch homozygous astrocytes

    Journal: bioRxiv

    doi: 10.1101/2025.01.21.634115

    (A) Schematic of the tau uptake assay in iPSC-derived astrocytes. (B) Representative overlaid histograms demonstrating the shift in fluorescence of cells with AF647 labeled tau (2N4R-P301L) aggregates (50nM, 3h) compared to cells treated with PBS. The dotted line represents the median AF647 intensity in the WT astrocytes treated with Tau. (C) Measurement of tau uptake by flow cytometry normalized to cells treated with PBS (n=3, 10000 cells each). (D) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of heparin normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 100 ug/ml heparin against cells with no treatment for each cell line. (E) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of RAP normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 500 nM RAP against cells with no treatment for each cell line. (F) Representative images of iPSC-derived astrocytes immunolabeled with anti-10E4, an HSPG marker. Green, 10E4; blue, Hoechst 33342; scale bar = 10 µm (G) Quantification of the expression of HSPGs using fluorescence intensity of anti-10E4 normalized to that of Hoechst per field of view (n=24 FOVs taken from 8 biological replicates, 3 FOVs per biological replicate) (H) Quantification of the expression of HSPG-related genes with RNA sequencing (n=3 for WT and n=6 for APOE3-Ch). Z-score of each HSPG gene is color coded and the size of the circle represents the mean expression. P-values were calculated using a Wald test for differential expression between groups (WT vs APOE3-Ch). Multiple testing correction was performed using the Benjamini-Hochberg method to control the false discovery rate (FDR). Genes with an adjusted p-value < 0.05 were considered statistically significant. Significantly upregulated genes were marked by red asterisks and significantly downregulated genes were marked by blue asterisks. (I) Representative images of iPSC-derived astrocytes immunolabeled with anti-LRP1. Green, LRP1; blue, Hoechst 33342; scale bar = 10 µm (J) Quantification of the expression of LRP1 using fluorescence intensity of anti-LRP1 normalized to that of Hoechst per field of view (n=12 FOVs taken from 4 biological replicates, 3 FOVs per biological replicate) All data are expressed as mean ± s.d. with individual data points shown. One-way ANOVA with Dunnett’s multiple comparison tests was performed to determine the significance unless otherwise specified. The results designated as “ns” are not significant; **p<0.01; ***p<0.001;****p<0.0001
    Figure Legend Snippet: (A) Schematic of the tau uptake assay in iPSC-derived astrocytes. (B) Representative overlaid histograms demonstrating the shift in fluorescence of cells with AF647 labeled tau (2N4R-P301L) aggregates (50nM, 3h) compared to cells treated with PBS. The dotted line represents the median AF647 intensity in the WT astrocytes treated with Tau. (C) Measurement of tau uptake by flow cytometry normalized to cells treated with PBS (n=3, 10000 cells each). (D) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of heparin normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 100 ug/ml heparin against cells with no treatment for each cell line. (E) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of RAP normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 500 nM RAP against cells with no treatment for each cell line. (F) Representative images of iPSC-derived astrocytes immunolabeled with anti-10E4, an HSPG marker. Green, 10E4; blue, Hoechst 33342; scale bar = 10 µm (G) Quantification of the expression of HSPGs using fluorescence intensity of anti-10E4 normalized to that of Hoechst per field of view (n=24 FOVs taken from 8 biological replicates, 3 FOVs per biological replicate) (H) Quantification of the expression of HSPG-related genes with RNA sequencing (n=3 for WT and n=6 for APOE3-Ch). Z-score of each HSPG gene is color coded and the size of the circle represents the mean expression. P-values were calculated using a Wald test for differential expression between groups (WT vs APOE3-Ch). Multiple testing correction was performed using the Benjamini-Hochberg method to control the false discovery rate (FDR). Genes with an adjusted p-value < 0.05 were considered statistically significant. Significantly upregulated genes were marked by red asterisks and significantly downregulated genes were marked by blue asterisks. (I) Representative images of iPSC-derived astrocytes immunolabeled with anti-LRP1. Green, LRP1; blue, Hoechst 33342; scale bar = 10 µm (J) Quantification of the expression of LRP1 using fluorescence intensity of anti-LRP1 normalized to that of Hoechst per field of view (n=12 FOVs taken from 4 biological replicates, 3 FOVs per biological replicate) All data are expressed as mean ± s.d. with individual data points shown. One-way ANOVA with Dunnett’s multiple comparison tests was performed to determine the significance unless otherwise specified. The results designated as “ns” are not significant; **p<0.01; ***p<0.001;****p<0.0001

    Techniques Used: Derivative Assay, Fluorescence, Labeling, Flow Cytometry, Comparison, Immunolabeling, Marker, Expressing, RNA Sequencing Assay, Control



    Similar Products

    98
    AMS Biotechnology primary antibody mouse anti 10e4
    (A) Schematic of the tau uptake assay in iPSC-derived astrocytes. (B) Representative overlaid histograms demonstrating the shift in fluorescence of cells with AF647 labeled tau (2N4R-P301L) aggregates (50nM, 3h) compared to cells treated with PBS. The dotted line represents the median AF647 intensity in the WT astrocytes treated with Tau. (C) Measurement of tau uptake by flow cytometry normalized to cells treated with PBS (n=3, 10000 cells each). (D) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of heparin normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 100 ug/ml heparin against cells with no treatment for each cell line. (E) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of RAP normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 500 nM RAP against cells with no treatment for each cell line. (F) Representative images of iPSC-derived astrocytes immunolabeled with <t>anti-10E4,</t> an HSPG marker. Green, 10E4; blue, Hoechst 33342; scale bar = 10 µm (G) Quantification of the expression of HSPGs using fluorescence intensity of anti-10E4 normalized to that of Hoechst per field of view (n=24 FOVs taken from 8 biological replicates, 3 FOVs per biological replicate) (H) Quantification of the expression of HSPG-related genes with RNA sequencing (n=3 for WT and n=6 for APOE3-Ch). Z-score of each HSPG gene is color coded and the size of the circle represents the mean expression. P-values were calculated using a Wald test for differential expression between groups (WT vs APOE3-Ch). Multiple testing correction was performed using the Benjamini-Hochberg method to control the false discovery rate (FDR). Genes with an adjusted p-value < 0.05 were considered statistically significant. Significantly upregulated genes were marked by red asterisks and significantly downregulated genes were marked by blue asterisks. (I) Representative images of iPSC-derived astrocytes immunolabeled with anti-LRP1. Green, LRP1; blue, Hoechst 33342; scale bar = 10 µm (J) Quantification of the expression of LRP1 using fluorescence intensity of anti-LRP1 normalized to that of Hoechst per field of view (n=12 FOVs taken from 4 biological replicates, 3 FOVs per biological replicate) All data are expressed as mean ± s.d. with individual data points shown. One-way ANOVA with Dunnett’s multiple comparison tests was performed to determine the significance unless otherwise specified. The results designated as “ns” are not significant; **p<0.01; ***p<0.001;****p<0.0001
    Primary Antibody Mouse Anti 10e4, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/9067/bio_rxiv__2025__01__21__634115-360-4-8?v=AMS+Biotechnology
    Average 98 stars, based on 1 article reviews
    primary antibody mouse anti 10e4 - by Bioz Stars, 2026-07
    98/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc rbbp4 7
    (A) Schematic of the tau uptake assay in iPSC-derived astrocytes. (B) Representative overlaid histograms demonstrating the shift in fluorescence of cells with AF647 labeled tau (2N4R-P301L) aggregates (50nM, 3h) compared to cells treated with PBS. The dotted line represents the median AF647 intensity in the WT astrocytes treated with Tau. (C) Measurement of tau uptake by flow cytometry normalized to cells treated with PBS (n=3, 10000 cells each). (D) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of heparin normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 100 ug/ml heparin against cells with no treatment for each cell line. (E) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of RAP normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 500 nM RAP against cells with no treatment for each cell line. (F) Representative images of iPSC-derived astrocytes immunolabeled with <t>anti-10E4,</t> an HSPG marker. Green, 10E4; blue, Hoechst 33342; scale bar = 10 µm (G) Quantification of the expression of HSPGs using fluorescence intensity of anti-10E4 normalized to that of Hoechst per field of view (n=24 FOVs taken from 8 biological replicates, 3 FOVs per biological replicate) (H) Quantification of the expression of HSPG-related genes with RNA sequencing (n=3 for WT and n=6 for APOE3-Ch). Z-score of each HSPG gene is color coded and the size of the circle represents the mean expression. P-values were calculated using a Wald test for differential expression between groups (WT vs APOE3-Ch). Multiple testing correction was performed using the Benjamini-Hochberg method to control the false discovery rate (FDR). Genes with an adjusted p-value < 0.05 were considered statistically significant. Significantly upregulated genes were marked by red asterisks and significantly downregulated genes were marked by blue asterisks. (I) Representative images of iPSC-derived astrocytes immunolabeled with anti-LRP1. Green, LRP1; blue, Hoechst 33342; scale bar = 10 µm (J) Quantification of the expression of LRP1 using fluorescence intensity of anti-LRP1 normalized to that of Hoechst per field of view (n=12 FOVs taken from 4 biological replicates, 3 FOVs per biological replicate) All data are expressed as mean ± s.d. with individual data points shown. One-way ANOVA with Dunnett’s multiple comparison tests was performed to determine the significance unless otherwise specified. The results designated as “ns” are not significant; **p<0.01; ***p<0.001;****p<0.0001
    Rbbp4 7, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/9067/pmc12695082-540-102-103?v=Cell+Signaling+Technology+Inc
    Average 93 stars, based on 1 article reviews
    rbbp4 7 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc rbap46 rbap48
    (A) Schematic of the tau uptake assay in iPSC-derived astrocytes. (B) Representative overlaid histograms demonstrating the shift in fluorescence of cells with AF647 labeled tau (2N4R-P301L) aggregates (50nM, 3h) compared to cells treated with PBS. The dotted line represents the median AF647 intensity in the WT astrocytes treated with Tau. (C) Measurement of tau uptake by flow cytometry normalized to cells treated with PBS (n=3, 10000 cells each). (D) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of heparin normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 100 ug/ml heparin against cells with no treatment for each cell line. (E) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of RAP normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 500 nM RAP against cells with no treatment for each cell line. (F) Representative images of iPSC-derived astrocytes immunolabeled with <t>anti-10E4,</t> an HSPG marker. Green, 10E4; blue, Hoechst 33342; scale bar = 10 µm (G) Quantification of the expression of HSPGs using fluorescence intensity of anti-10E4 normalized to that of Hoechst per field of view (n=24 FOVs taken from 8 biological replicates, 3 FOVs per biological replicate) (H) Quantification of the expression of HSPG-related genes with RNA sequencing (n=3 for WT and n=6 for APOE3-Ch). Z-score of each HSPG gene is color coded and the size of the circle represents the mean expression. P-values were calculated using a Wald test for differential expression between groups (WT vs APOE3-Ch). Multiple testing correction was performed using the Benjamini-Hochberg method to control the false discovery rate (FDR). Genes with an adjusted p-value < 0.05 were considered statistically significant. Significantly upregulated genes were marked by red asterisks and significantly downregulated genes were marked by blue asterisks. (I) Representative images of iPSC-derived astrocytes immunolabeled with anti-LRP1. Green, LRP1; blue, Hoechst 33342; scale bar = 10 µm (J) Quantification of the expression of LRP1 using fluorescence intensity of anti-LRP1 normalized to that of Hoechst per field of view (n=12 FOVs taken from 4 biological replicates, 3 FOVs per biological replicate) All data are expressed as mean ± s.d. with individual data points shown. One-way ANOVA with Dunnett’s multiple comparison tests was performed to determine the significance unless otherwise specified. The results designated as “ns” are not significant; **p<0.01; ***p<0.001;****p<0.0001
    Rbap46 Rbap48, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/9067/pmc12274581-292-15-16?v=Cell+Signaling+Technology+Inc
    Average 93 stars, based on 1 article reviews
    rbap46 rbap48 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    R&D Systems c terminal fragment 9067 sl
    (A) Schematic of the tau uptake assay in iPSC-derived astrocytes. (B) Representative overlaid histograms demonstrating the shift in fluorescence of cells with AF647 labeled tau (2N4R-P301L) aggregates (50nM, 3h) compared to cells treated with PBS. The dotted line represents the median AF647 intensity in the WT astrocytes treated with Tau. (C) Measurement of tau uptake by flow cytometry normalized to cells treated with PBS (n=3, 10000 cells each). (D) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of heparin normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 100 ug/ml heparin against cells with no treatment for each cell line. (E) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of RAP normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 500 nM RAP against cells with no treatment for each cell line. (F) Representative images of iPSC-derived astrocytes immunolabeled with <t>anti-10E4,</t> an HSPG marker. Green, 10E4; blue, Hoechst 33342; scale bar = 10 µm (G) Quantification of the expression of HSPGs using fluorescence intensity of anti-10E4 normalized to that of Hoechst per field of view (n=24 FOVs taken from 8 biological replicates, 3 FOVs per biological replicate) (H) Quantification of the expression of HSPG-related genes with RNA sequencing (n=3 for WT and n=6 for APOE3-Ch). Z-score of each HSPG gene is color coded and the size of the circle represents the mean expression. P-values were calculated using a Wald test for differential expression between groups (WT vs APOE3-Ch). Multiple testing correction was performed using the Benjamini-Hochberg method to control the false discovery rate (FDR). Genes with an adjusted p-value < 0.05 were considered statistically significant. Significantly upregulated genes were marked by red asterisks and significantly downregulated genes were marked by blue asterisks. (I) Representative images of iPSC-derived astrocytes immunolabeled with anti-LRP1. Green, LRP1; blue, Hoechst 33342; scale bar = 10 µm (J) Quantification of the expression of LRP1 using fluorescence intensity of anti-LRP1 normalized to that of Hoechst per field of view (n=12 FOVs taken from 4 biological replicates, 3 FOVs per biological replicate) All data are expressed as mean ± s.d. with individual data points shown. One-way ANOVA with Dunnett’s multiple comparison tests was performed to determine the significance unless otherwise specified. The results designated as “ns” are not significant; **p<0.01; ***p<0.001;****p<0.0001
    C Terminal Fragment 9067 Sl, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/9067/pm40402573-286-10-17?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    c terminal fragment 9067 sl - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc anti rbbp4
    (A) Schematic of the tau uptake assay in iPSC-derived astrocytes. (B) Representative overlaid histograms demonstrating the shift in fluorescence of cells with AF647 labeled tau (2N4R-P301L) aggregates (50nM, 3h) compared to cells treated with PBS. The dotted line represents the median AF647 intensity in the WT astrocytes treated with Tau. (C) Measurement of tau uptake by flow cytometry normalized to cells treated with PBS (n=3, 10000 cells each). (D) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of heparin normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 100 ug/ml heparin against cells with no treatment for each cell line. (E) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of RAP normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 500 nM RAP against cells with no treatment for each cell line. (F) Representative images of iPSC-derived astrocytes immunolabeled with <t>anti-10E4,</t> an HSPG marker. Green, 10E4; blue, Hoechst 33342; scale bar = 10 µm (G) Quantification of the expression of HSPGs using fluorescence intensity of anti-10E4 normalized to that of Hoechst per field of view (n=24 FOVs taken from 8 biological replicates, 3 FOVs per biological replicate) (H) Quantification of the expression of HSPG-related genes with RNA sequencing (n=3 for WT and n=6 for APOE3-Ch). Z-score of each HSPG gene is color coded and the size of the circle represents the mean expression. P-values were calculated using a Wald test for differential expression between groups (WT vs APOE3-Ch). Multiple testing correction was performed using the Benjamini-Hochberg method to control the false discovery rate (FDR). Genes with an adjusted p-value < 0.05 were considered statistically significant. Significantly upregulated genes were marked by red asterisks and significantly downregulated genes were marked by blue asterisks. (I) Representative images of iPSC-derived astrocytes immunolabeled with anti-LRP1. Green, LRP1; blue, Hoechst 33342; scale bar = 10 µm (J) Quantification of the expression of LRP1 using fluorescence intensity of anti-LRP1 normalized to that of Hoechst per field of view (n=12 FOVs taken from 4 biological replicates, 3 FOVs per biological replicate) All data are expressed as mean ± s.d. with individual data points shown. One-way ANOVA with Dunnett’s multiple comparison tests was performed to determine the significance unless otherwise specified. The results designated as “ns” are not significant; **p<0.01; ***p<0.001;****p<0.0001
    Anti Rbbp4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/9067/pmc11941746-82-70-71?v=Cell+Signaling+Technology+Inc
    Average 93 stars, based on 1 article reviews
    anti rbbp4 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    90
    Neogen isoamylase from pseudomonas sp. (ec 6.2.1.68, 200 units/ml, cas: 9067-73-6)
    (A) Schematic of the tau uptake assay in iPSC-derived astrocytes. (B) Representative overlaid histograms demonstrating the shift in fluorescence of cells with AF647 labeled tau (2N4R-P301L) aggregates (50nM, 3h) compared to cells treated with PBS. The dotted line represents the median AF647 intensity in the WT astrocytes treated with Tau. (C) Measurement of tau uptake by flow cytometry normalized to cells treated with PBS (n=3, 10000 cells each). (D) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of heparin normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 100 ug/ml heparin against cells with no treatment for each cell line. (E) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of RAP normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 500 nM RAP against cells with no treatment for each cell line. (F) Representative images of iPSC-derived astrocytes immunolabeled with <t>anti-10E4,</t> an HSPG marker. Green, 10E4; blue, Hoechst 33342; scale bar = 10 µm (G) Quantification of the expression of HSPGs using fluorescence intensity of anti-10E4 normalized to that of Hoechst per field of view (n=24 FOVs taken from 8 biological replicates, 3 FOVs per biological replicate) (H) Quantification of the expression of HSPG-related genes with RNA sequencing (n=3 for WT and n=6 for APOE3-Ch). Z-score of each HSPG gene is color coded and the size of the circle represents the mean expression. P-values were calculated using a Wald test for differential expression between groups (WT vs APOE3-Ch). Multiple testing correction was performed using the Benjamini-Hochberg method to control the false discovery rate (FDR). Genes with an adjusted p-value < 0.05 were considered statistically significant. Significantly upregulated genes were marked by red asterisks and significantly downregulated genes were marked by blue asterisks. (I) Representative images of iPSC-derived astrocytes immunolabeled with anti-LRP1. Green, LRP1; blue, Hoechst 33342; scale bar = 10 µm (J) Quantification of the expression of LRP1 using fluorescence intensity of anti-LRP1 normalized to that of Hoechst per field of view (n=12 FOVs taken from 4 biological replicates, 3 FOVs per biological replicate) All data are expressed as mean ± s.d. with individual data points shown. One-way ANOVA with Dunnett’s multiple comparison tests was performed to determine the significance unless otherwise specified. The results designated as “ns” are not significant; **p<0.01; ***p<0.001;****p<0.0001
    Isoamylase From Pseudomonas Sp. (Ec 6.2.1.68, 200 Units/Ml, Cas: 9067 73 6), supplied by Neogen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/9067/10__1016_slash_j__foodhyd__2025__111069-43-11-24?v=Neogen
    Average 90 stars, based on 1 article reviews
    isoamylase from pseudomonas sp. (ec 6.2.1.68, 200 units/ml, cas: 9067-73-6) - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    93
    R&D Systems slit3 recombinant protein
    (A) Schematic of the tau uptake assay in iPSC-derived astrocytes. (B) Representative overlaid histograms demonstrating the shift in fluorescence of cells with AF647 labeled tau (2N4R-P301L) aggregates (50nM, 3h) compared to cells treated with PBS. The dotted line represents the median AF647 intensity in the WT astrocytes treated with Tau. (C) Measurement of tau uptake by flow cytometry normalized to cells treated with PBS (n=3, 10000 cells each). (D) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of heparin normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 100 ug/ml heparin against cells with no treatment for each cell line. (E) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of RAP normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 500 nM RAP against cells with no treatment for each cell line. (F) Representative images of iPSC-derived astrocytes immunolabeled with <t>anti-10E4,</t> an HSPG marker. Green, 10E4; blue, Hoechst 33342; scale bar = 10 µm (G) Quantification of the expression of HSPGs using fluorescence intensity of anti-10E4 normalized to that of Hoechst per field of view (n=24 FOVs taken from 8 biological replicates, 3 FOVs per biological replicate) (H) Quantification of the expression of HSPG-related genes with RNA sequencing (n=3 for WT and n=6 for APOE3-Ch). Z-score of each HSPG gene is color coded and the size of the circle represents the mean expression. P-values were calculated using a Wald test for differential expression between groups (WT vs APOE3-Ch). Multiple testing correction was performed using the Benjamini-Hochberg method to control the false discovery rate (FDR). Genes with an adjusted p-value < 0.05 were considered statistically significant. Significantly upregulated genes were marked by red asterisks and significantly downregulated genes were marked by blue asterisks. (I) Representative images of iPSC-derived astrocytes immunolabeled with anti-LRP1. Green, LRP1; blue, Hoechst 33342; scale bar = 10 µm (J) Quantification of the expression of LRP1 using fluorescence intensity of anti-LRP1 normalized to that of Hoechst per field of view (n=12 FOVs taken from 4 biological replicates, 3 FOVs per biological replicate) All data are expressed as mean ± s.d. with individual data points shown. One-way ANOVA with Dunnett’s multiple comparison tests was performed to determine the significance unless otherwise specified. The results designated as “ns” are not significant; **p<0.01; ***p<0.001;****p<0.0001
    Slit3 Recombinant Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/9067/10__1007_slash_s10853___024___10379___z-62-5-22?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    slit3 recombinant protein - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    Image Search Results


    (A) Schematic of the tau uptake assay in iPSC-derived astrocytes. (B) Representative overlaid histograms demonstrating the shift in fluorescence of cells with AF647 labeled tau (2N4R-P301L) aggregates (50nM, 3h) compared to cells treated with PBS. The dotted line represents the median AF647 intensity in the WT astrocytes treated with Tau. (C) Measurement of tau uptake by flow cytometry normalized to cells treated with PBS (n=3, 10000 cells each). (D) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of heparin normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 100 ug/ml heparin against cells with no treatment for each cell line. (E) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of RAP normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 500 nM RAP against cells with no treatment for each cell line. (F) Representative images of iPSC-derived astrocytes immunolabeled with anti-10E4, an HSPG marker. Green, 10E4; blue, Hoechst 33342; scale bar = 10 µm (G) Quantification of the expression of HSPGs using fluorescence intensity of anti-10E4 normalized to that of Hoechst per field of view (n=24 FOVs taken from 8 biological replicates, 3 FOVs per biological replicate) (H) Quantification of the expression of HSPG-related genes with RNA sequencing (n=3 for WT and n=6 for APOE3-Ch). Z-score of each HSPG gene is color coded and the size of the circle represents the mean expression. P-values were calculated using a Wald test for differential expression between groups (WT vs APOE3-Ch). Multiple testing correction was performed using the Benjamini-Hochberg method to control the false discovery rate (FDR). Genes with an adjusted p-value < 0.05 were considered statistically significant. Significantly upregulated genes were marked by red asterisks and significantly downregulated genes were marked by blue asterisks. (I) Representative images of iPSC-derived astrocytes immunolabeled with anti-LRP1. Green, LRP1; blue, Hoechst 33342; scale bar = 10 µm (J) Quantification of the expression of LRP1 using fluorescence intensity of anti-LRP1 normalized to that of Hoechst per field of view (n=12 FOVs taken from 4 biological replicates, 3 FOVs per biological replicate) All data are expressed as mean ± s.d. with individual data points shown. One-way ANOVA with Dunnett’s multiple comparison tests was performed to determine the significance unless otherwise specified. The results designated as “ns” are not significant; **p<0.01; ***p<0.001;****p<0.0001

    Journal: bioRxiv

    Article Title: Protective mechanisms against Alzheimer’s Disease in APOE3-Christchurch homozygous astrocytes

    doi: 10.1101/2025.01.21.634115

    Figure Lengend Snippet: (A) Schematic of the tau uptake assay in iPSC-derived astrocytes. (B) Representative overlaid histograms demonstrating the shift in fluorescence of cells with AF647 labeled tau (2N4R-P301L) aggregates (50nM, 3h) compared to cells treated with PBS. The dotted line represents the median AF647 intensity in the WT astrocytes treated with Tau. (C) Measurement of tau uptake by flow cytometry normalized to cells treated with PBS (n=3, 10000 cells each). (D) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of heparin normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 100 ug/ml heparin against cells with no treatment for each cell line. (E) Measurement of tau uptake in cells treated with Tau (50nM, 3h) and various concentrations of RAP normalized to cells treated with PBS (n=3, 10000 cells each). Statistical significance is determined by two-way ANOVA with uncorrected Fisher’s LSD multiple comparison tests. Displayed is the multiple comparison of cells treated with 500 nM RAP against cells with no treatment for each cell line. (F) Representative images of iPSC-derived astrocytes immunolabeled with anti-10E4, an HSPG marker. Green, 10E4; blue, Hoechst 33342; scale bar = 10 µm (G) Quantification of the expression of HSPGs using fluorescence intensity of anti-10E4 normalized to that of Hoechst per field of view (n=24 FOVs taken from 8 biological replicates, 3 FOVs per biological replicate) (H) Quantification of the expression of HSPG-related genes with RNA sequencing (n=3 for WT and n=6 for APOE3-Ch). Z-score of each HSPG gene is color coded and the size of the circle represents the mean expression. P-values were calculated using a Wald test for differential expression between groups (WT vs APOE3-Ch). Multiple testing correction was performed using the Benjamini-Hochberg method to control the false discovery rate (FDR). Genes with an adjusted p-value < 0.05 were considered statistically significant. Significantly upregulated genes were marked by red asterisks and significantly downregulated genes were marked by blue asterisks. (I) Representative images of iPSC-derived astrocytes immunolabeled with anti-LRP1. Green, LRP1; blue, Hoechst 33342; scale bar = 10 µm (J) Quantification of the expression of LRP1 using fluorescence intensity of anti-LRP1 normalized to that of Hoechst per field of view (n=12 FOVs taken from 4 biological replicates, 3 FOVs per biological replicate) All data are expressed as mean ± s.d. with individual data points shown. One-way ANOVA with Dunnett’s multiple comparison tests was performed to determine the significance unless otherwise specified. The results designated as “ns” are not significant; **p<0.01; ***p<0.001;****p<0.0001

    Article Snippet: To probe for HSPGs, primary antibody mouse anti-10E4 (Amsbio, Cat. No. 370255-S) was applied at a 1:100 dilution in 5% normal goat serum.

    Techniques: Derivative Assay, Fluorescence, Labeling, Flow Cytometry, Comparison, Immunolabeling, Marker, Expressing, RNA Sequencing Assay, Control